Supplemental Figure 1 from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Authors:
- Stephen M. AnsellSAStephen M. Ansell
- Michael B. MarisMMMichael B. Maris
- Alexander M. LesokhinALAlexander M. Lesokhin
- Robert W. ChenRCRobert W. Chen
- Ian W. FlinnIFIan W. Flinn
- Ahmed SawasASAhmed Sawas
- Mark D. MindenMMMark D. Minden
- Diego VillaDVDiego Villa
- Mary-Elizabeth M. PercivalMPMary-Elizabeth M. Percival
- Anjali S. AdvaniAAAnjali S. Advani
- James M. ForanJFJames M. Foran
- Steven M. HorwitzSHSteven M. Horwitz
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)